FDA Approved: TAVNEOS — Original Application (ChemoCentryx, Inc.)

View source ↗

Summary

FDA approved Tavneos (avacopan) from ChemoCentryx for adults with ANCA-associated vasculitis, in combination with standard therapy, including granulomatosis wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis

Drugs mentioned

• TAVNEOS (avacopan)

Snippet

ORIG AP for TAVNEOS (AVACOPAN)